Taiko Pharmaceutical

4574.TPharmaceutical

Filed as TAIKO PHARMACEUTICAL CO.,LTD. (2022-08–2026-08)

Key numbers · FY ended 2025-12

Revenue¥6.4bn+1.7% YoY Operating income¥459m-27.0% YoY Net income (owners)¥923m+2.8% YoY Total assets¥12.3bn-5.0% YoY EPS (basic)¥18.38+2.7% YoY

Full financial history and reports →

Stock price4574 · View chart ↗

Open the price chart on TradingView.

Latest filings

Fri, Apr 24 · JST1 filing

15:36MATERIALTaiko Pharmaceutical · Event with a material impact on financial position

Wed, Aug 20 · JST1 filing

15:32MATERIALTaiko Pharmaceutical · Change in parent company or specified subsidiary

Fri, Mar 28 · JST1 filing

15:36MATERIALTaiko Pharmaceutical · Change in parent company or specified subsidiary

All filings →